Cutler Group’s Orphazyme A/S ORPH Stock Holding History

Cutler Group’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,400	Closed	-$1K	–	6426
2021 Q4	$1K	Sell	3,400 -10,500	-76%	-$37.1K	﹤0.01%	5273
2021 Q3	$2K	Sell	13,900 -42,200	-75%	-$217K	﹤0.01%	5190
2021 Q2	$37K	Buy	+56,100	New	+$452K	﹤0.01%	2757

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cutler Group's ORPH Position: Q1 2022 in Review

Cutler Group sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 3,576 shares — an estimated $8K sold.

Cutler Group first reported a position in ORPH in Q2 2021 and held it in 3 quarters. The position peaked at $268K in Q2 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Cutler Group reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Cutler Group sold 3,576 Orphazyme A/S shares in Q1 2022, an estimated $8K.
Cutler Group first reported a position in Orphazyme A/S in Q2 2021 and held it in 3 quarters.
Cutler Group's Orphazyme A/S position peaked at $268K in Q2 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.